Geron (GERN) Common Equity (2010 - 2026)
Geron's Common Equity was $218.61 million in Q2 2026, down 15.8% from $259.53 million a year earlier and down 4.6% from the prior quarter.
Powered by 
Analysis
Geron (GERN) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Geron came in at $225.87 million, down 19.4% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 1.4% (FY2020 to FY2025).
- In earlier years, Common Equity was $280.32 million in FY2024 (+13.1%), $247.95 million in FY2023 (+209.9%), $80 million in FY2022 (-36.7%) and $126.42 million in FY2021 (-40.1%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q4 2022.
- Compared with a year earlier, Common Equity has declined for six straight quarters, with an average decline of 11.1% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2023 (growth of 234.5%); the worst was Q1 2022 (a decline of 51.5%).
- Per Business Quant data, GERN's Common Equity in the three quarters before Q2 2026 was $229.11 million (Q1 2026), $225.87 million (Q4 2025) and $248.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Geron | 777.25 Mn | -574.46 Mn | - | 218.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218.61 Mn |
| Mar 31, 2026 | 229.11 Mn |
| Dec 31, 2025 | 225.87 Mn |
| Sep 30, 2025 | 248.71 Mn |
| Jun 30, 2025 | 259.53 Mn |
| Mar 31, 2025 | 268.24 Mn |
| Dec 31, 2024 | 280.32 Mn |
| Sep 30, 2024 | 292.28 Mn |
| Jun 30, 2024 | 306.70 Mn |
| Mar 31, 2024 | 344.87 Mn |
| Dec 31, 2023 | 247.95 Mn |
| Sep 30, 2023 | 290.61 Mn |
| Jun 30, 2023 | 298.43 Mn |
| Mar 31, 2023 | 326.06 Mn |
| Dec 31, 2022 | 80.00 Mn |
| Sep 30, 2022 | 108.17 Mn |
| Jun 30, 2022 | 142.05 Mn |
| Mar 31, 2022 | 97.49 Mn |
| Dec 31, 2021 | 126.42 Mn |
| Sep 30, 2021 | 151.55 Mn |
API Access
Geron Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GERN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GERN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GERN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();